Abbvie, Novo Nordisk and Takeda have the best reputations among pharmaceutical companies, according to a new study, which also suggests that overall public perceptions of the industry are improving.
Cambrex, a leading manufacturer of small molecules and generic active pharmaceutical ingredients (APIs), has expanded large scale manufacturing capacity at its cGMP facility in Karlskoga, Sweden, and introduced additional continuous flow manufacturing to produce high-purity intermediates. The expansion includes the installation of new multi-purpose reactors ranging from 4m3 to 12m3 and upgrading of the control room within an existing plant on site. This extra capacity increases the large-scale manufacturing capabilities of the Karlskoga facility, which supports clients’ development projects from R&D through to large scale commercial manufacturing. Installation of all new equipment, including a 9m³ hydrogenation reactor, is expected to be completed by 3Q17.
Reverse osmosis membrane elements from specialty chemicals company Lanxess have successfully completed a year-long practical test in Germany's largest industrial water treatment plant. The new ASD feed spacers showed a consistently high level of rejection, with less blockage from fouling or biological growth over the year, compared with standard elements.
Ten start-ups will see their ideas for more sustainable chemistry move a step closer to reality after being named winners of AkzoNobel’s Imagine Chemistry challenge.
The manufacturing industry trade organization YCF is spearheading the establishment of a new personal care cluster in the north of England.
U.S. Water, a subsidiary of ALLETE and a leading national provider of integrated solutions for water treatment, celebrates 20 years in business today, June 9th. Thank you to Our Employees and Their Families
PSE Europe is a new trade show that is intended to help build new markets for the polyurethane industry across the EMEA regions. Taking place at the MOC Veranstaltungscenter Munich in Germany, this inaugural event will take place from 27th to 29th June 2017.
CPhI’s inaugural event in the North American market breathed new life into InformEx as more than 7000 people gathered alongside more than 550 exhibitors in central Philadelphia on 16-18 May. We met with Angelini, Cambrex, CordenPharma, Daikin, Flamma, Hovione, PCI Pharma Services, Navin Fluorine, Norac Pharma, Optima Chemical, REACHLaw, Robinson Brothers, SOCMA, Vertellus, Zeon and others, to discuss news, views and opportunities in North America.
The pilot plan for a Marketing Authorization Holder (MAH) system is a revolutionary process in the development of biopharmaceutical innovation in China. As well as making it easier for China’s biotechs to progress their own products, the scheme allows overseas drug license holders to use contract facilities in China, enabling easier access to the market. China is an emerging giant in the pharma sector, with around 6,500 pharmaceutical manufacturing companies producing 1,500 types of APIs. The biggest production volumes are for Vitamins C & E, penicillin and paracetamol. In addition, there are 16,000 medical device and equipment manufacturing companies, which produce about 3,000 kinds of products such as MRI and CT.
Gelest has unveiled its new SiBRID TM-31, a personal care silicone vehicle with solubility and volatility characteristics similar to cyclomethicone (D5).